OTCMKTS:EXETF

Extendicare Stock Forecast, Price & News

$6.52
-0.05 (-0.76 %)
(As of 08/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.52
$6.54
50-Day Range
$6.52
$7.04
52-Week Range
$3.48
$7.06
Volume3,291 shs
Average Volume4,625 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EXETF News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.


Extendicare logo

About Extendicare

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a net of 121 LTC homes and retirement communities, including 69 owned and 52 contract services, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was founded in 1968 and is based in Markham, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.12 out of 5 stars

Analyst Opinion: 2.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Extendicare (OTCMKTS:EXETF) Frequently Asked Questions

Is Extendicare a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Extendicare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXETF, but not buy additional shares or sell existing shares.
View analyst ratings for Extendicare
or view top-rated stocks.

What stocks does MarketBeat like better than Extendicare?

Wall Street analysts have given Extendicare a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Extendicare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Extendicare's next earnings date?

Extendicare is scheduled to release its next quarterly earnings announcement on Wednesday, August 11th 2021.
View our earnings forecast for Extendicare
.

How has Extendicare's stock price been impacted by Coronavirus (COVID-19)?

Extendicare's stock was trading at $4.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EXETF shares have increased by 33.1% and is now trading at $6.52.
View which stocks have been most impacted by COVID-19
.

How often does Extendicare pay dividends? What is the dividend yield for Extendicare?

Extendicare announced a dividend on Tuesday, July 20th. Stockholders of record on Friday, July 30th will be given a dividend of $0.3812 per share on Monday, August 16th. This represents a dividend yield of 5.57%. The ex-dividend date is Thursday, July 29th.
View Extendicare's dividend history
.

What price target have analysts set for EXETF?

3 equities research analysts have issued 1 year target prices for Extendicare's stock. Their forecasts range from $7.00 to $9.00. On average, they anticipate Extendicare's share price to reach $8.00 in the next year. This suggests a possible upside of 22.7% from the stock's current price.
View analysts' price targets for Extendicare
or view top-rated stocks among Wall Street analysts.

Who are Extendicare's key executives?

Extendicare's management team includes the following people:
  • Dr. Michael R. Guerriere, CEO, Pres & Director (Age 57, Pay $894.1k)
  • Mr. David E. Bacon, Sr. VP & CFO
  • Mr. John Toffoletto, Sr. VP, Chief Legal Officer & Corp. Sec.
  • Ms. Elaine E. Everson, VP of Corp. Devel.
  • Ms. Leslie Sarauer, Sr. VP & Chief HR Officer (Age 59, Pay $415.48k)
  • Mr. Ali Mohammad Mir, VP, ParaMed Operations
  • Ms. Jillian E. Fountain, VP of Investor Relations
  • Ms. Lisa Pearson, VP of Public Affairs
  • Dr. Matthew Morgan, Chief Medical Officer
  • Mr. Bruce Wienberg, Sr. VP of Residential Care Operations

What is Extendicare's stock symbol?

Extendicare trades on the OTCMKTS under the ticker symbol "EXETF."

How do I buy shares of Extendicare?

Shares of EXETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Extendicare's stock price today?

One share of EXETF stock can currently be purchased for approximately $6.52.

How many employees does Extendicare have?

Extendicare employs 23,000 workers across the globe.

What is Extendicare's official website?

The official website for Extendicare is www.extendicare.com.

How can I contact Extendicare?

The company can be reached via phone at (905) 470-4000.


This page was last updated on 8/5/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.